Manulife US REIT secures SGX waiver to delay FY2025 results to Mar, 18 2026

SGX Filings
02/25

Manulife US Real Estate Investment Trust said on Feb, 25 2026 that Singapore Exchange Regulation has no objection to its request for an extension until Mar, 18 2026 to release its unaudited financial statements for the year ended Dec, 31 2025, waiving the usual Rule 705(1) deadline.

The trust sought extra time while it negotiates the potential sale of one property. Management believes the agreed sale price would represent the most accurate carrying value for the asset and wants that figure reflected in the upcoming results. If the transaction does not materialise, the accounts will be announced earlier.

The waiver requires the trust to disclose specific information about the extension and to confirm board approval. Manulife US REIT said all waiver conditions have been met.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10